Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06659146 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Thermotherapy in Addition to SOC Palliative Radiotherapy

Study acronym: ThermoRad wIRA
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

  1. Primary and study completion dates: Oct 13, 2027 to Mar 1, 2028v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Site details revised at 2 of 2 sites
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to investigate the efficacy and safety profile of superficial hyperthermia (wIRA) in addition to standard of care (SOC) palliative radiotherapy in patients with inoperable/incurable locally advanced or recurrent/metastatic HNSCC or cutaneous SCC superficial tumours not suitable for radical treatment. The investigators will assess the best objective response rate (ORR) of patients with Inoperable/incurable or recurrent/metastatic HNSCC or cSCC with superficial lesion(s) treated with the combination of superficial hyperthermia (wIRA) and palliative radiotherapy.
Trial Details
NCT Number NCT06659146
Lead Sponsor King's College London
Collaborators: Guy's and St Thomas' NHS Foundation Trust
Conditions
(from sponsor)		 Head and Neck Squamous Cell Carcinoma, Cutaneous Squamous Cell Carcinoma, Breast Cancer Recurrent
Related terms Squamous Cell Carcinoma of Head and Neck
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov